IL-1RAcP/IL-1 R3 Protein, Cynomolgus (HEK293, His)

IL-1RAcP is a co-receptor for IL1RL2, IL1R1 and IL1RL1 in the IL-36, IL-1 and IL-33 signaling system, respectively. IL-1RAcP is an essential component of the IL-1 receptor and plays an essential role in the inflammatory process^[1][2]. IL-1RAcP/IL-1 R3 Protein, Cynomolgus (HEK293, His) is a recombinant cynomolgus IL-1RAcP protein with a His tag at the C-terminus and is expressed in HEK293 cells. It consists of 359 amino acids (M1-E359).

Interleukin-1 receptor accessory protein (IL-1RAcP), also known as IL-1 R3, belongs to the immunoglobulin (Ig) superfamily. IL-1RAcP can be detected in liver, skin, placenta, thymus and lung.
The cynomolgus IL-1RAcP protein shares 99.30% a.a sequence identity with human, 88.60% identity with rat and 88.42% identity with mouse.
IL-1RAcP contains three Ig-like domains and a cytoplasmic domain named Toll/IL-1 receptor (TIR) (position: 403-546 a.a), which has been implicated in signal transduction. IL-1RAcP also contains a single transmembrane region. IL-1RAcP is a co-receptor for IL1RL2, IL1R1 and IL1RL1 in the IL-36, IL-1 and IL-33 signaling system, respectively. IL-1RAcP is an indispensible molecule in the IL-1 receptor signal transduction complex, links events at the plasma membrane level to downstream signaling pathways, mediates interleukin-1-dependent transcription factor activation and gene expression.
IL-1RAcP plays an essential role in the inflammatory process and can be used for the research of obesity, diabetics, endometriosis, atherosclerosis, and so on^[1][2][3].

Measured by its ability to inhibit IL-1 alpha -induced IL-8 secretion in HepG2 human hepatocellular carcinoma cells. The ED₅₀ for this effect is 1.163 µg/mL in the presence of 1 μg/mL of recombinant human IL-1 R2 and 50 pg/mL rhIL-1 alpha, corresponding to a specific activity is 619.963 U/mg.

Cynomolgus

HEK293

C-His

P59822/NP_001028132.1 (S21-E359)

574387  [NCBI]

SERCDDWGLDTMRQIQVFEDEPARIKCPLFEHFLKFNYSTAHSAGLTLIWYWTRQDRDLEEPINFRLPENRISKEKDVLWFRPTLLNDTGNYTCMLRNTTYCSKVAFPLEVVQKDSCFNSPMKLPVHKLYIEYGIQRITCPNVDGYFPSSVKPTITWYMGCYKIQNFNNVIPEGMNLSFLIAFISNNGNYTCVVTYPENGRTFHLTRTLTVKVVGSPKNAVPPVIHSPNDHVVYEKEPGEELLIPCTVYFSFLMDSRNEVWWTIDGKKPDDIPIDVTINESISHSRTEDETRTQILSIKKVTSEDLKRSYVCHARSAKGEVAKAATVKQKVPAPRYTVE

Approximately 55-70 kDa due to the glycosylation

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized powder.

Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.

<1 EU/μg, determined by LAL method.

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH₂O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Stored at -20°C for 2 years. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Room temperature in continental US; may vary elsewhere.

• [1]. Neveu PJ, et al. Mechanisms of behavioral and neuroendocrine effects of interleukin-1 in mice. Ann N Y Acad Sci. 2000;917:175-85.  [Content Brief]

  [2]. Zarezadeh Mehrabadi A, et al. The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions. Immunology. 2022 May;166(1):38-46.  [Content Brief]

  [3]. Wesche H, et al. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem. 1997 Mar 21;272(12):7727-31.  [Content Brief]